Institut de Cancerologie Strasbourg

Strasbourg 67033

0 studies enrolling now · 2 studies all time

What they study most

Advanced/Metastatic Cancer, Relapsed or Refractory Multiple Myeloma

Studies at this site

• Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. — Running, not enrolling
• A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed